Response envelope analysis for quantitative evaluation of drug combinations

Area of Science:

• Pharmacology
• Computational Biology
• Drug Discovery

Background:

• Synergy in drug combinations is crucial across biology, chemistry, pharmacology, and medicine.
• Accurate identification of drug interaction effects (synergy, additivity, antagonism) relies on appropriate additivity models.
• Current methods for analyzing drug combination effects have notable limitations.

Purpose of the Study:

• To introduce a computational framework, Response Envelope Analysis (REA), for evaluating drug combination effects.
• To establish a quantitatively stringent additivity model for synergy identification without prior knowledge of inhibition mechanisms.
• To demonstrate the application and advantages of REA using real-world drug combination data.

Main Methods:

• Development of a computational framework, Response Envelope Analysis (REA).
• Utilizing 3D response surfaces derived from generalized Loewe Additivity and Bliss Independence models.
• Defining a response envelope based on these two extreme interaction models.

Main Results:

• REA accurately evaluates drug combination effects, including synergy, additivity, and antagonism.
• The response envelope provides a stringent additivity model independent of inhibition mechanisms.
• Application to anticancer and antibiotic combination data showed REA's superior accuracy and consistency compared to existing methods.

Conclusions:

• Response Envelope Analysis (REA) provides a robust and accurate computational framework for drug combination analysis.
• REA overcomes limitations of existing methods, offering more consistent and reliable identification of drug interactions.
• The open-source REA software package facilitates its adoption in drug discovery and related fields.